LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.86 | 84.90 | 540 | 7680 | 0.0703 | 0.3293 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.86 | 84.90 | 4066 | 7680 | 0.5294 | 0.8136 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.86 | 84.90 | 529 | 7680 | 0.0689 | 0.3251 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.86 | 84.90 | 4470 | 7680 | 0.5820 | 0.8402 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 89.57 | 84.90 | 564 | 7494 | 0.0753 | 0.3404 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 89.57 | 84.90 | 4177 | 7494 | 0.5573 | 0.8271 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 89.57 | 84.90 | 575 | 7494 | 0.0767 | 0.3444 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 89.57 | 84.90 | 4613 | 7494 | 0.6155 | 0.8553 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 91.27 | 84.90 | 574 | 7420 | 0.0774 | 0.3449 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 91.27 | 84.90 | 4362 | 7420 | 0.5879 | 0.8419 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 91.27 | 84.90 | 622 | 7420 | 0.0838 | 0.3618 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 91.27 | 84.90 | 4707 | 7420 | 0.6344 | 0.8637 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.98 | 84.90 | 588 | 7257 | 0.0810 | 0.3520 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.98 | 84.90 | 4444 | 7257 | 0.6123 | 0.8528 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.98 | 84.90 | 653 | 7257 | 0.0900 | 0.3742 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.98 | 84.90 | 4823 | 7257 | 0.6645 | 0.8766 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 94.68 | 84.90 | 612 | 7000 | 0.0874 | 0.3639 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 94.68 | 84.90 | 4524 | 7000 | 0.6463 | 0.8674 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 94.68 | 84.90 | 620 | 7000 | 0.0886 | 0.3666 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 94.68 | 84.90 | 4974 | 7000 | 0.7105 | 0.8955 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 2.66 | 84.90 | 545 | 285 | 1.9073 | 1.8920 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 2.66 | 84.90 | 524 | 285 | 1.8338 | 1.8278 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | C15 |